November 24, 2010   |   ISSUE: 5

Happy Thanksgiving from All of Us At New Line Medical!

Omega 3 May Help Prevent Gum Disease

In this nationally representative sample, higher dietary intakes of DHA and, to a lesser degree, EPA, were associated with lower prevalence of periodontitis. Interventional studies are needed to confirm the potential protective effects of n-3 fatty acids on periodontitis.

 
 
 
 

The Effect Of Dental Care On Cardiovascular Disease Outcome

Studies show a relationship between oral inflammatory processes and cardiovascular risk factors, suggesting that dental care may reduce the risk of cardiovascular disease (CVD) events. However, due to the differences between men and women in the development and presentation of CVD, such effects may vary by sex.

Whole Grains Promote Cardiovascular Health & Lean Body

Different aspects of diet may be differentially related to body fat distribution. The purpose of this study was to assess associations between whole- and refined-grain intake and abdominal subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT).

Remarkable Discovery - A Cure For The Common Cold

In a dramatic breakthrough that could affect millions of lives, scientists have been able to show for the first time that the body's immune defences can destroy the common cold virus after it has actually invaded the inner sanctum of a human cell, a feat that was believed until now to be impossible.

Scientists Turn Skin Into Blood

In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.The discovery, published in the prestigious science journal Nature today, could mean that in the foreseeable future people needing blood for surgery, cancer treatment or treatment of other blood conditions like anemia will be able to have blood created from a patch of their own skin to provide transfusions.

A1cNow+

The A1cNow+ test is annually certified by the National Glycohemoglobin Standardization Program (NGSP) and therefore traceable to the DCCT.

Further, each lot is factory calibrated using a set of blood samples that have been quantitated by an NGSP certified laboratory using an NGSP certified method. Since in-field calibration is neither needed nor possible, the user cannot alter the accuracy of the test. Allowing for the normal variation seen with all laboratory methods, a 7% A1C using A1cNow+ will thus be, on average, the same as a 7% A1C on other instruments that are also calibrated to NGSP standards.

Bayer's A1cNow+ monitor provides accurate, in-office A1c results, empowering physicians to make on the spot treatment decisions for their patients with diabetes.

Getting quick, accurate A1C results just got even easier with the new A1cNow+ Sampler.

FAST. EASY. ACCURATE.